Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,643 | 605 | 98.2% |
| Education | $209.78 | 6 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,198 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $1,091 | 53 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $979.83 | 41 | $0 (2024) |
| ABBVIE INC. | $926.54 | 47 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $627.06 | 32 | $0 (2024) |
| Galderma Laboratories, L.P. | $613.31 | 37 | $0 (2024) |
| LEO Pharma Inc. | $555.03 | 30 | $0 (2024) |
| Lilly USA, LLC | $544.01 | 26 | $0 (2024) |
| MAYNE PHARMA INC. | $520.06 | 32 | $0 (2022) |
| Amgen Inc. | $514.55 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,748 | 77 | GENZYME CORPORATION ($355.48) |
| 2023 | $1,831 | 77 | Janssen Biotech, Inc. ($401.09) |
| 2022 | $1,462 | 71 | GENZYME CORPORATION ($307.35) |
| 2021 | $1,337 | 72 | SUN PHARMACEUTICAL INDUSTRIES INC. ($199.55) |
| 2020 | $830.15 | 44 | Galderma Laboratories, L.P. ($97.08) |
| 2019 | $1,731 | 97 | Ortho Dermatologics, a division of Bausch Health US, LLC ($142.63) |
| 2018 | $1,444 | 85 | Mayne Pharma Inc. ($225.34) |
| 2017 | $1,469 | 88 | Allergan Inc. ($227.46) |
All Payment Transactions
611 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/22/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Immunology | ||||||
| 12/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND, EBGLYSS | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Immunology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $17.01 | General |
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.83 | General |
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 4,622 | 9,782 | $752,312 | $442,787 |
| 2022 | 24 | 4,166 | 8,540 | $645,023 | $380,255 |
| 2021 | 22 | 2,569 | 5,221 | $395,694 | $244,563 |
| 2020 | 20 | 2,236 | 4,637 | $354,601 | $212,022 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,014 | 1,854 | $205,425 | $130,827 | 63.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 767 | 1,049 | $137,420 | $86,273 | 62.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 786 | 1,293 | $66,800 | $40,384 | 60.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 565 | 848 | $80,292 | $32,560 | 40.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 56 | 58 | $29,885 | $22,346 | 74.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 418 | 3,371 | $44,467 | $19,589 | 44.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 252 | 252 | $35,360 | $19,314 | 54.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 120 | 158 | $21,878 | $14,490 | 66.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 29 | 31 | $18,350 | $12,821 | 69.9% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 33 | 34 | $16,660 | $12,361 | 74.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 96 | 114 | $17,110 | $12,182 | 71.2% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 51 | 60 | $15,060 | $10,901 | 72.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 77 | 82 | $24,235 | $9,163 | 37.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 77 | 99 | $7,550 | $4,533 | 60.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 57 | 101 | $7,300 | $3,769 | 51.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 21 | $4,200 | $2,986 | 71.1% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $6,175 | $2,550 | 41.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 23 | 23 | $7,190 | $2,475 | 34.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 40 | $2,800 | $1,760 | 62.9% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 15 | $1,910 | $1,016 | 53.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 31 | $950.00 | $316.25 | 33.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 86 | 229 | $1,295 | $171.15 | 13.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 890 | 1,493 | $166,930 | $107,422 | 64.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 670 | 871 | $114,880 | $73,691 | 64.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 691 | 1,094 | $56,680 | $35,383 | 62.4% |
About Dr. Robin Schaffran, M.D
Dr. Robin Schaffran, M.D is a Procedural Dermatology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790785822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robin Schaffran, M.D has received a total of $11,853 in payments from pharmaceutical and medical device companies, with $1,748 received in 2024. These payments were reported across 611 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($11,643).
As a Medicare-enrolled provider, Schaffran has provided services to 13,593 Medicare beneficiaries, totaling 28,180 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Procedural Dermatology
- Location Beverly Hills, CA
- Active Since 07/29/2005
- Last Updated 12/13/2010
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790785822
Products in Payments
- DUPIXENT (Biological) $1,766
- Otezla (Drug) $756.83
- TREMFYA (Drug) $665.81
- TALTZ (Drug) $544.01
- DORYX (Drug) $460.60
- COSENTYX (Biological) $396.95
- SKYRIZI (Biological) $372.18
- EUCRISA (Drug) $325.59
- EPIDUO FORTE (Drug) $253.64
- ENSTILAR (Drug) $240.78
- LIBTAYO (Biological) $235.82
- RINVOQ (Biological) $219.11
- OPZELURA (Drug) $185.12
- REMICADE (Biological) $183.77
- PICATO (Drug) $178.42
- DUPIXENT DUPILUMAB INJECTION (Biological) $176.50
- Winlevi (Drug) $175.20
- BOTOX COSMETIC (Biological) $150.51
- VTAMA (Drug) $139.37
- Mupirocin Cream (Drug) $132.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Procedural Dermatology Doctors in Beverly Hills
Harry Saperstein, M.d, M.D
Procedural Dermatology — Payments: $9,939
Annette Gottlieb, M.d, M.D
Procedural Dermatology — Payments: $3,019
Dr. Joan Osder, M.d, M.D
Procedural Dermatology — Payments: $671.81
Dr. Wendy Hoffman, M.d, M.D
Procedural Dermatology — Payments: $206.08
Dr. Sharon Mcbeth, M.d, M.D
Procedural Dermatology — Payments: $22.34